相关实验视频
Updated: Jul 20, 2026

08:29
Establishment and Culture of Patient-Derived Breast Organoids
Published on: February 17, 2023
4.4K
来自患者的瘤器官:个性化癌症治疗的临床前平台
Sebastien Taurin1, Reem Alzahrani1, Sahar Aloraibi1
1Department of Molecular Medicine, College of Medicine and Health Sciences, Princess Al-Jawhara Center for Molecular Medicine and Inherited Disorders, Arabian Gulf University, Manama, Bahrain.
Translational oncology
|December 2, 2024
概括
患者衍生瘤器官 (PDTO) 通过对患者瘤进行镜像,为癌症研究提供了个性化的方法. 虽然存在挑战,但PDTO在预测患者药物反应和推进临床试验方面表现有前途.
科学领域:
- 在瘤学瘤学.
- 再生医学是一种再生医学.
- 翻译癌症研究 翻译癌症研究
背景情况:
- 患者衍生瘤器官 (PDTO) 是来自患者瘤的创新模型.
- PDTO复制了原始瘤的遗传和分子概况,有助于个性化医学.
- 建立PDTO的成功率是可变的,受癌症类型,组织质量和培养介质的影响.
研究的目的:
- 突出PDTO在癌症研究和个性化医学中的重要性.
- 讨论PDTO在研究瘤生物学和药物反应方面的潜力和挑战.
- 在临床环境中探索PDTO和患者结果之间的相关性.
主要方法:
- 使用来自患者的瘤样本进行器官培养.
- 标志着有机体的遗传和分子特性.
- 评估PDTO患者的药物反应,并与患者的结果相关联.
主要成果:
- PDTOs成功地保留了母瘤的关键特征.
- 指出PDTO建立成功的变化,需要标准化的协议.
- 新兴研究表明,PDTO药物反应与患者的治疗结果之间存在相关性.
结论:
- PDTO是个性化癌症治疗研究的宝贵工具.
- 标准化和验证对于可靠的PDTO数据临床解释至关重要.
- 将PDTO纳入临床试验可以加速开发新型癌症治疗方法.
相关概念视频
Cancer
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

